Anagnostics

Anagnostics aims to include the marker in a new version of its Hybcell Inflammation integrated sepsis monitoring test.

The researchers are also developing the method in tandem with a more extensive pathogen profiling diagnostic platform from Swedish startup Q-linea.

NEW YORK (GenomeWeb) – Austrian molecular diagnostics firm Anagnostics recently launched a new assay designed to detect sepsis-associated bacteria and fungi using a single array.

Anagnostics is planning to expand its sales and marketing activities in the EU as well as the US as it narrows its focus to its nascent integrated sepsis diagnostics business.

Austrian molecular diagnostics firm Anagnostics said this week that it has received CE-IVD approval for two tests based on its Hybcell cylindrical microarray platform.

Austrian molecular diagnostics firm Anagnostics said this week that it is now using Scienion's SciFlexarrayer to produce its cylindrical Hybcell arrays.

NEW YORK (GenomeWeb News) – Scienion and Anagnostics Bioanalysis today said that Anagnostics is using Scienion's SciFlexArrayer in the production of Anagnostics' new products focused on integrating sepsis testing.

Austrian array company Anagnostics recently achieved a CE-IVD mark for a test that could help clinicians guide treatment for patients with sepsis. Separately, the firm announced a new distribution partnership in Belgium, further expanding its presence in Europe.

Nanosphere has appointed Roy Davis to its board of directors.

This story has been updated to include comments from company executives.
Austrian array company Anagnostics Bioanalysis recently announced a deal with Molzym to develop and launch a test for sepsis.

Pages

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.